← back to search

John T. Leppert

Stanford University · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Renal cell carcinoma treatment, Kidney Stones and Urolithiasis Treatments, Prostate Cancer Diagnosis and Treatment, and Bladder and Urothelial Cancer Treatments.
h-index
41
citations
8,521
works
337
NIH funding
primary concept
Medicine
email

Recent publications

Perioperative Integration of Palliative Care and Urology for Patients With Serious Urologic Illness: A Qualitative Need Finding Inquiry
Journal of Pain and Symptom Management 2025cited by 3position: middledoi
Ambient air pollution and urological cancer risk: A systematic review and meta-analysis of epidemiological evidence
Nature Communications 2024cited by 44position: middledoi
Estimated Effect of Parathyroidectomy on Long-Term Kidney Function in Adults With Primary Hyperparathyroidism
Annals of Internal Medicine 2023cited by 17position: middledoi
Hypocitraturia and Risk of Bone Disease in Patients With Kidney Stone Disease
JBMR Plus 2023cited by 4position: middledoi
Patient and physician perspectives on treatments for low-risk prostate cancer: a qualitative study
BMC Cancer 2023cited by 0position: middledoi
Assessment of Second Primary Cancer Risk Among Men Receiving Primary Radiotherapy vs Surgery for the Treatment of Prostate Cancer
JAMA Network Open 2022cited by 39position: middledoi
Renal Morbidity Following Radical Cystectomy in Patients with Bladder Cancer
European Urology Open Science 2022cited by 18position: lastdoi
Accurate detection of benign and malignant renal tumor subtypes with MethylBoostER: An epigenetic marker–driven learning framework
Science Advances 2022cited by 11position: middledoi
National Imaging Trends for Suspected Urinary Stone Disease in the Emergency Department
JAMA Internal Medicine 2022cited by 7position: middledoi
The m <sup>6</sup> A RNA demethylase FTO is a HIF-independent synthetic lethal partner with the VHL tumor suppressor
Proceedings of the National Academy of Sciences 2020cited by 101position: middledoi
S100A10 Is a Critical Mediator of GAS6/AXL–Induced Angiogenesis in Renal Cell Carcinoma
Cancer Research 2019cited by 60position: middledoi
Organoid Modeling of the Tumor Immune Microenvironment
Cell 2018cited by 1,436position: middledoi
Utilization of Renal Mass Biopsy in Patients With Renal Cell Carcinoma
Urology 2014cited by 88position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Glenn M. Chertow · Center for Clinical Research (United States)5 papers (2014–2023)Alan C. Pao · Palo Alto University4 papers (2022–2023)Calyani Ganesan · Palo Alto University4 papers (2022–2023)James D. Brooks · Intel (United States)4 papers (2014–2023)Benjamin I. Chung · Palo Alto University3 papers (2014–2024)Maria E. Montez‐Rath · Stanford University2 papers (2023–2023)Rie von Eyben · Palo Alto University2 papers (2019–2020)Amber W. Trickey · Palo Alto University2 papers (2022–2023) · 2 papers (2022–2023)Amato J. Giaccia · University of Oxford2 papers (2019–2020)Yiren Xiao · Palo Alto University2 papers (2019–2020)Anh N. Diep · Palo Alto University2 papers (2019–2020)Donna M. Peehl · City College of San Francisco2 papers (2019–2020)Erinn B. Rankin · Cancer Research Center2 papers (2019–2020)Hongjuan Zhao · Palo Alto University2 papers (2019–2020)Simon Conti · Palo Alto University1 papers (2022–2022)James P. Broughton · Mammoth Biosciences (United States)1 papers (2020–2020)Alex H. S. Harris · Palo Alto University1 papers (2023–2023)Christopher G. Smith · University of Cambridge1 papers (2022–2022)Christina Curtis · Stanford University1 papers (2020–2020)